Pembrolizumab-induced sclerosing cholangitis in a lung adenocarcinoma patient with a remarkable response to chemotherapy: a case report
Kentaro Sato, Manabu Hayashi, Kazumichi Abe, Masashi Fujita, Atsushi Takahashi, Hiromasa Ohira
Topics & Concepts
MedicineIntrahepatic bile ductsUrsodeoxycholic acidBile ductGastroenterologyInternal medicinePembrolizumabChemotherapyAdenocarcinomaHepatologyJaundiceElevated alkaline phosphataseBile duct cancerPrimary sclerosing cholangitisBiliary tractAlkaline phosphataseLung cancerCancerImmunotherapyBiochemistryDiseaseEnzymeChemistryCancer Immunotherapy and BiomarkersLiver Diseases and ImmunityInterstitial Lung Diseases and Idiopathic Pulmonary Fibrosis